OSR Holdings Provides Transparency Update on Equity Financing Instruments
✍️ Advertorial Desk, .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow, Class, Wp-Block-Co-Authors-Plus, Display Inline, .Wp-Block-Co-Authors-Plus-Avatar, Where Img, Height Auto Max-Width, Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar, Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright📅 July 31, 2025 12:00 AM🕐 Scraped: November 17, 2025
BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovation approaches to health and wellness to support global health outcomes, today provided a transparency update regarding its Equity Line of Credit (ELOC) agreement with White Lion GBM Innovation Fund and related convertible instruments.
Highlights:
Total shares issued to date
📰
Continue Reading on Laotian Times
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.
